Empowering best practice

Our Digital Therapy Platform empowers clinicians to deliver the best clinical and commercial outcomes.
 "

A True Impact Investment

We are committed to sustainable value creation for society in the long-term while generating a financial return for investors and payors.

Our Digital Therapy Platform

With leading engineering, science and AI we ensure best practice clinical processes and quality of patient care, embedded in our integrated Digital Therapy Platform.

Leaders in Innovative Healthcare

We are seasoned business leaders and global pioneers with expertise in healthcare, science and technology backed by our committed investors.

Get in touch to request access to the Investor Room

Thomas Mechtersheimer
Founder & CEO

Our neurocare clinics

We operate over 20 clinics in Europe, United States and in Australia.  The Psychiatry, Psychology and mental health teams working in our clinics,  are trained in best-practice personalization techniques of TMS, Neurofeebdack or tDCS and help more than 3000 patients annually.  We help treat patients with Depression, ADHD, OCD, Sleep Disorders and more.

neurocare-sydney-2022

Our Digital Therapy Platform

With leading engineering, science, and AI we ensure best practice clinical processes and quality patient care, embedded in our integrated Digital Therapy Platform (the 'DTP').

neurocare_dtp_cloud

neurocare academy LMS

Discover neurocare's online Learning Management System, helping third-party clinicians from all over the world gain access to our neurocare academy training courses.

learn-from-home-online-neuromodulation-courses

Scientific publications

Discover the growing list of literature and publications supporting the evidence behind neurocare protocols of TMS (Transcranial Magnetic Stimulation) for Depression and other disorders, as well as Neurofeedback for Sleep & ADHD. Plus much more.

NIBS research
neurocare group - Image Gallery
neurocare-clinician-and-tms-patient
Neurofeedback-therapy-with-neuroCare-Clinics-768x503-3-1
research-tms-transcranial-magnetic-stimulation
neurocare-sydney-2022
neuroCademy tDCS workshop
Mann-bei-tDCS-Therapie
Latest Press Releases
neurocare group AG announces publication in International Journal of Clinical and Health Psychology confirming the importance of sleep for...
neurocare group AG is pleased to announce the signing of a cooperation and agency agreement (“Agreements”) for its Digital Therapy Platform...
neurocare group AG has entered into strategic cooperation with Stimit AG (“Stimit”), a company developing solutions for non-invasive...
neurocare group is is pleased to announce that it has obtained a patent grant from the Japan Patent Office with respect to the patent...
neurocare group is pleased to announce that patient enrollment has recently started for a clinical trial evaluating the cost-effectiveness...
neurocare group is pleased to announce the recent approval of the Apollo TMS system for the treatment of depression by the Therapeutic...
neurocare group is pleased to announce its participation at the upcoming Clinical TMS Society 10th Annual Meeting in Chicago, IL held May...
neurocare is pleased to announce the recent expansion of its neurocare clinic network in the US.

Contact

Get in touch to learn more about innovations in mental health and performance

Contact Contact